UK drugs firm GlaxoSmithKline believes it has developed a vaccine for the H5N1 deadly strain of avian flu.

...GlaxoSmithKline ...company's Avandia diabetes drug. Glaxo representatives and officials of the U.S. Food and Drug Administration will attend hearings today by the U.S. House Oversight Committee on ...

...GlaxoSmithKline ...company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris Pharmaceuticals Inc. Net income fell to 1.31 billion pounds ($2.61 billion), or 24.2 pence a ...

U.S. personal incomes were down, while consumer inflation rose to a 17-year, but consumers... 8/2008 Reuters

CNBC interviews Jean-Pierre Garnier, chief of pharmaceutical giant GlaxoSmithKline, on the company's earnings decline from generic competition.